Testicular cancer in 2023: Current status and recent progress
CA: A Cancer Journal for Clinicians · 2024-03 · 74 (2) · 167-186
DOI: 10.3322/caac.21819 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 10.11.2023. Verfasst von Deaglan J McHugh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Testicular germ cell tumor (GCT) is the most common solid tumor in adolescent and young adult men. Progress in the management of GCT has been made in the last 50 years, with a substantial improvement in cure rates for advanced disease, from 25% in the 1970s to nearly 80%. However, relapsed or platinum‐refractory disease occurs in a proportion, 20% of whom will die from disease progression. This article reviews the current evidence‐based treatments for extracranial GCT, the acute and chronic toxic effects that may result, and highlights contemporary advances and progress in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Weill Cornell Medicine, New York, New York, USA.
- Cancer Research, College of Medicine and Health, University College Cork, Cork, Ireland.
- Medical Oncology Department, Cork University Hospital, Cork, Ireland.
ORCID-Profile: Deaglan J McHugh, Jack P Gleeson
Zitieren
APA
McHugh, D. J., Gleeson, J. P., & Feldman, D. R. (2024). Testicular cancer in 2023: Current status and recent progress. CA: A Cancer Journal for Clinicians, 74(2), 167-186. https://doi.org/10.3322/caac.21819
Vancouver
McHugh DJ, Gleeson JP, Feldman DR. Testicular cancer in 2023: Current status and recent progress. CA: A Cancer Journal for Clinicians. 2024;74(2):167-186. doi:10.3322/caac.21819
BibTeX
@article{McHugh2024,
author = {McHugh, Deaglan J and Gleeson, Jack P and Feldman, Darren R},
title = {Testicular cancer in 2023: Current status and recent progress},
journal = {CA: A Cancer Journal for Clinicians},
year = {2024},
volume = {74},
number = {2},
pages = {167--186},
doi = {10.3322/caac.21819}
}
EUVIMED